Cencora | COR - Sales Revenues

Stock Price
355.65
Daily Change
25.68 7.78%
Monthly
2.74%
Yearly
44.50%
Q1 Forecast
348.16

Cencora reported $85.9B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Ambu A/S DKK 1.47B 40M Sep/2025
Amplifon EUR 563.3M 29.55M Sep/2025
Apollo Hospitals Enterprise Ltd INR 63.04B 5.54B Sep/2025
Avanos Medical USD 177.8M 2.8M Sep/2025
Brookdale Senior Living USD 813.16M 34.92M Sep/2025
Cencora USD 85.9B 5.2B Sep/2025
Convatec Group USD 1.18B 0 Jun/2025
Diasorin EUR 280M 26M Sep/2025
Encompass Health USD 1.48B 20M Sep/2025
Enovis USD 548.9M 15.64M Sep/2025
GE HealthCare Technologies USD 5.14B 137M Sep/2025
Gulf Medical Proj AED 185.37M 5.32M Jun/2025
Hoya 244.7B 10.21B Dec/2025
Med Life RON 787.96M 8.36M Sep/2025
Oriola-kd EUR 463.3M 30.6M Sep/2025
Rede D'or Sao Luiz BRL 14.6B 480M Sep/2025
Siemens Healthineers EUR 5.4B 920M Dec/2025
Solventum Corp USD 2.1B 60M Sep/2025
Sonova Holding CHF 1.82B 216.8M Dec/2025
Supermax Corporation Bhd MYR 205.56M 50.82M Sep/2025
Zimmer Biomet Holdings USD 2B 80M Sep/2025